YANCOPOULOS GEORGE 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Jun 12, 2024
Insider Transaction Report
Form 4
YANCOPOULOS GEORGE
DirectorEVP CSO & Pres Regn Res Labs
Transactions
- Gift
Common Stock
2024-06-10−75,799→ 0 total(indirect: by 2022 GRAT II) - Gift
Common Stock
2024-06-10+37,900→ 56,048 total(indirect: By Children)
Holdings
- 180,000(indirect: By Trust)
Common Stock
- 5,903(indirect: By 401(k))
Common Stock
- 868,994
Common Stock
Footnotes (1)
- [F1]As investment trustee of trusts for the benefit of the reporting person's children.